0001567619-19-021063.txt : 20191112 0001567619-19-021063.hdr.sgml : 20191112 20191112181237 ACCESSION NUMBER: 0001567619-19-021063 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191111 FILED AS OF DATE: 20191112 DATE AS OF CHANGE: 20191112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Campbell James H CENTRAL INDEX KEY: 0001757390 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 191211184 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE, SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0306 4 2019-11-11 0 0000722723 HANGER, INC. HNGR 0001757390 Campbell James H 10910 DOMAIN DRIVE, SUITE 300 AUSTIN TX 78758 0 1 0 0 SVP, Chief Clinical Officer Common Stock 2019-11-11 4 S 0 2925 23.8097 D 20152 D Stock Options (right to buy) 12.77 2027-05-19 Common Stock 27328 27328 D Performance Share Units 2020-05-19 Common Stock 10931 10931 D Consists of (i) unvested restricted shares totaling 5,220 shares of stock from an initial grant of 5,220 shares of restricted stock that begins to vest on March 8, 2020; (ii)unvested restricted shares and fully vested shares totaling 6,268 shares of stock from an initial grant of 6,710 shares of restricted stock that begins to vest on March 9, 2019; (iii) unvested restricted shares and fully vested shares totaling 4,820 shares of stock from an initial grant of 7,029 shares of restricted stock that begins to vest on March 8, 2018; [continued in next footnote] (iv) unvested restricted shares and fully vested shares totaling 1,316 shares of stock from an initial grant of 3,000 shares of restricted stock that begins to vest on October 11, 2017; and (v) unvested restricted shares and fully vested shares totaling 2,528 shares of stock from an initial grant of 6,008 shares of restricted stock that begins to vest on March 7, 2017. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020. Performance Share Units ("PSUs") were granted under the Company's Special Equity Plan. Each PSU represents a contingent right to receive one share of common stock if predetermined levels of absolute common stock price compounded annual growth rate are achieved over a three-year performance period ending on the third anniversary of the grant date. The number of PSUs shown in the table represents the maximum number that could be earned; the target number is one-half the maximum number. /s/ Jessica Lochmann Allen, Attorney-in-Fact for James H. Campbell 2019-11-12